Skip to main content
Search
Search
Anywhere
Quick Search anywhere
Enter words / phrases / DOI / ISBN / keywords / authors / etc
Search
Advanced Search
Login
Skip main navigation
Open Drawer Menu
Close Drawer Menu
Home
Journal of Comparative Effectiveness Research
Journal of Patient Centricity
The Evidence Base
Skip slideshow
Journal of Comparative Effectiveness Research
ISSN (print): 2042-6305 • ISSN (online): 2042-6313
Impact Factor: 2.8 (2025) • CiteScore: 4.2 (2025) • Open Access
Read more
Journal of Patient Centricity
ISSN (online): 2978-8579
In partnership with the PCSIG • Open Access
Read more
The Evidence Base
Latest news, opinion and insight into hot topics including RWE, HEOR, HTA and market access
Read more
Latest
Real-world treatment patterns and clinical outcomes of patients with primary biliary cholangitis in the United States
Nisreen Shamseddine
,
Hongbo Yang
,
Su Zhang
,
Dongni Ye
,
Shravanthi Seshasayee
,
Jingyi Chen
,
Sonal Kumar
, and
Kris V Kowdley
Journal of Comparative Effectiveness Research
12 Aug 2026
Burden of fatigue or pruritus in patients with primary biliary cholangitis: a United States matched case–control study
Sonal Kumar
,
Nisreen Shamseddine
,
Hongbo Yang
,
Su Zhang
,
Jingyi Chen
, and
Kris V Kowdley
Journal of Comparative Effectiveness Research
12 Aug 2026
Hot off the press: Part two of our pick of articles within HTA and RWE published in July 2026
The Evidence Base
12 Aug 2026
AARP analysis examines potential $200 billion Medicare savings from international drug pricing
The Evidence Base
11 Aug 2026
Journal of Comparative Effectiveness Research
Open access, peer-reviewed journal offering rapid publication for all aspects of HEOR and related areas
Read More
FROM THE EVIDENCE BASE
12 Aug 2026
Hot off the press: Part two of our pick of articles within HTA and RWE published in July 2026
11 Aug 2026
Hot off the press: Part one of our pick of articles within HTA and RWE published in July 2026
7 Aug 2026
Learning health systems, real-world evidence, and payer decision-making: Key takeaways from the Duke-Margolis 2026 State of Real-World Evidence Policy
12 Aug 2026
Hot off the press: Part two of our pick of articles within HTA and RWE published in July 2026
11 Aug 2026
Hot off the press: Part one of our pick of articles within HTA and RWE published in July 2026
4 Aug 2026
UK's Innovative Licensing and Access Pathway awards Innovation Passports to two investigational liver cancer and dementia medicines
12 Aug 2026
Hot off the press: Part two of our pick of articles within HTA and RWE published in July 2026
11 Aug 2026
AARP analysis examines potential $200 billion Medicare savings from international drug pricing
10 Aug 2026
What does the evidence tell us about the 340B Drug Pricing Program?
The Evidence Base
Online hub providing the latest news, opinion and insights into HEOR, RWE, HTA and more
Read More
FROM THE EVIDENCE BASE
12 Aug 2026
Hot off the press: Part two of our pick of articles within HTA and RWE published in July 2026
11 Aug 2026
AARP analysis examines potential $200 billion Medicare savings from international drug pricing
11 Aug 2026
Hot off the press: Part one of our pick of articles within HTA and RWE published in July 2026
10 Aug 2026
What does the evidence tell us about the 340B Drug Pricing Program?
.png)
.png)
